Please ensure Javascript is enabled for purposes of website accessibility
Home > Support > Customer Publications

Sacubitril/valsartan attenuates hypoxia/reoxygenation-induced cardiomyocyte injury by modulating macrophage polarization via TLR4/NF-κB pathway

Release date: 2026-04-13  View count: 0
Recommendation

Get a free quote